Literature DB >> 29152929

The role of echocardiography in Kawasaki disease.

Brian W McCrindle1, Barbara Cifra1.   

Abstract

Kawasaki disease (KD) is an acute, self-limited vasculitis affecting young children. It can result in coronary artery abnormalities in a significant proportion of patients, especially if the diagnosis is missed or treatment gets delayed. Echocardiography is the imaging modality of choice for detection of coronary artery abnormalities and assessment of myocardial function. It is also useful for characterization and risk stratification of patients with KD. Echocardiography should be performed at the time of diagnosis and then again at 1-2 weeks and 4-6 weeks after treatment, for uncomplicated cases who do not have significant coronary artery involvement. Use of a standardized imaging protocol is necessary to detect and characterize coronary artery abnormalities, including standardization of measurements (Z scores). For patients with evolving abnormalities, more frequent assessment is necessary in order to detect thromboses in aneurysms. Long-term prognosis and management is dependent on both the maximal and current Z scores of aneurysms. Patients with large or giant aneurysms (i.e., Z score ≥ 10) are at the highest risk of both thrombosis and stenosis. Such patients need careful follow-up for subsequent cardiovascular events. Many of them would be candidates for advanced cardiovascular imaging and may require revascularization therapy. Serial echocardiography plays a key role in surveillance. In addition, stress echocardiography has proven useful as a modality to assess for inducible myocardial ischemia. Intravascular ultrasound has been recommended for functional and structural assessment of coronary arteries in children with KD.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Kawasaki disease; coronary arteries; coronary artery aneurysms; echocardiography; intravascular ultrasound; stress echocardiography

Mesh:

Year:  2017        PMID: 29152929     DOI: 10.1111/1756-185X.13216

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  12 in total

1.  Differences in Sensitivity Between the Japanese and Z Score Criteria for Detecting Coronary Artery Abnormalities Resulting from Kawasaki Disease.

Authors:  Ryusuke Ae; Yoshihide Shibata; Tohru Kobayashi; Koki Kosami; Masanari Kuwabara; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Hiroya Masuda; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2022-09-19       Impact factor: 1.838

Review 2.  Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.

Authors:  M A Bordea; C Costache; A Grama; A I Florian; I Lupan; G Samasca; D Deleanu; P Makovicky; P Makovicky; K Rimarova
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

3.  Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease.

Authors:  Junqing Gao; Xu Wang; Lingyan Li; Hong Zhang; Ruiqing He; Bingyu Han; Zongjun Li
Journal:  J Healthc Eng       Date:  2021-08-06       Impact factor: 2.682

4.  Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions.

Authors:  Dima Chbeir; Jean Gaschignard; Ronan Bonnefoy; Constance Beyler; Isabelle Melki; Albert Faye; Ulrich Meinzer
Journal:  Pediatr Rheumatol Online J       Date:  2018-07-18       Impact factor: 3.054

Review 5.  Report on advances for pediatricians in 2018: allergy, cardiology, critical care, endocrinology, hereditary metabolic diseases, gastroenterology, infectious diseases, neonatology, nutrition, respiratory tract disorders and surgery.

Authors:  Carlo Caffarelli; Francesca Santamaria; Carla Mastrorilli; Angelica Santoro; Brunella Iovane; Maddalena Petraroli; Valeria Gaeta; Rosita Di Pinto; Melissa Borrelli; Sergio Bernasconi; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2019-10-16       Impact factor: 2.638

Review 6.  Cardiac Involvement of COVID-19: A Comprehensive Review.

Authors:  Wei-Ting Chang; Han Siong Toh; Chia-Te Liao; Wen-Liang Yu
Journal:  Am J Med Sci       Date:  2020-10-06       Impact factor: 2.378

Review 7.  Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.

Authors:  Alessandra Marchesi; Donato Rigante; Rolando Cimaz; Angelo Ravelli; Isabella Tarissi de Jacobis; Alessandro Rimini; Fabio Cardinale; Marco Cattalini; Andrea De Zorzi; Rosa Maria Dellepiane; Patrizia Salice; Aurelio Secinaro; Andrea Taddio; Paolo Palma; Maya El Hachem; Elisabetta Cortis; Maria Cristina Maggio; Giovanni Corsello; Alberto Villani
Journal:  Ital J Pediatr       Date:  2021-01-25       Impact factor: 2.638

Review 8.  Potential role of an athlete-focused echocardiogram in sports eligibility.

Authors:  Stefano Palermi; Alessandro Serio; Marco Vecchiato; Felice Sirico; Francesco Gambardella; Fabrizio Ricci; Franco Iodice; Juri Radmilovic; Vincenzo Russo; Antonello D'Andrea
Journal:  World J Cardiol       Date:  2021-08-26

Review 9.  Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.

Authors:  Jayakanthan Kabeerdoss; Rakesh Kumar Pilania; Reena Karkhele; T Sathish Kumar; Debashish Danda; Surjit Singh
Journal:  Rheumatol Int       Date:  2020-11-21       Impact factor: 2.631

10.  Value of serial echocardiography in diagnosing Kawasaki's disease.

Authors:  Maria Hörl; Holger Michel; Stephan Döring; Markus-Johann Dechant; Florian Zeman; Michael Melter; Stephan Gerling
Journal:  Eur J Pediatr       Date:  2020-09-21       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.